Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Inicio Explorar nav.journalClub Tendencias

⌘+K

© Synapse Social LLC, 2026

Política de privacidad

Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India | Synapse

January 15, 2021Open Access

Cost-Effectiveness of Temozolamide for Treatment of Glioblastoma Multiforme in India

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Temozolamide is not cost-effective for treatment of patients with GBM in India. This evidence should be used while framing guidelines for treatment and price regulation.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Gupta et al. (Fri,) studied this question.

synapsesocial.com/papers/69e7489d67c6782a4be40b0f https://doi.org/https://doi.org/10.1200/go.20.00288

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo